By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Titan Pharmaceuticals, Inc. 

400 Oyster Point Boulevard, Suite 505

South San Francisco  California  94080-1921  U.S.A.
Phone: 650-244-4990 Fax: 650-244-4956



Company News
Titan Pharmaceuticals (TTP) Adds ProNeura Implant For Hypothyroidism To Product Development Pipeline 11/17/2015 12:44:04 PM
Titan Pharmaceuticals (TTP) Reports Third Quarter 2015 Financial Results 11/17/2015 12:42:15 PM
Titan Pharmaceuticals (TTP) Schedules Conference Call To Review Third Quarter 2015 Financial Results 11/11/2015 11:58:52 AM
Titan Pharmaceuticals (TTP) Announces Uplisting To NASDAQ 10/12/2015 11:19:10 AM
Titan Pharmaceuticals (TTP) Provides Opinion Of Counsel Covering Issuance And Resale Of Shares Underlying Public Warrants 10/9/2015 11:55:12 AM
Titan Pharmaceuticals (TTP) Announces Reverse Stock Split 9/29/2015 1:22:42 PM
Titan Pharmaceuticals (TTP) Announces FDA's Acceptance Of Resubmission Of New Drug Application For Probuphine 9/28/2015 2:21:18 PM
Titan Pharmaceuticals (TTP) To Present At Rodman & Renshaw 17th Annual Global Investment Conference 9/8/2015 12:49:33 PM
Titan Pharmaceuticals (TTP) Announces Resubmission Of The New Drug Application For Probuphine For The Maintenance Treatment Of Opioid Addiction 8/31/2015 11:32:55 AM
Titan Pharmaceuticals (TTP) Reports Second Quarter 2015 Financial Results 8/14/2015 10:39:53 AM